Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers September 22, 2017
Pharmacy Choice - Pharmaceutical News - Admera Health Expands Asian Footprint with Three Strategic Partnerships [Sudan Tribune] - September 22, 2017

Pharmacy News Article

 9/13/17 - Admera Health Expands Asian Footprint with Three Strategic Partnerships [Sudan Tribune]

(GlobeNewswire) - Today, Admera Health announced agreements expanding Admeras portfolio of molecular diagnostics to Asia, including but not limited to Singapore, Hong Kong, Korea and Taiwan.

Admera Health, a molecular diagnostic company, offers the most comprehensive pharmacogenomics testing services available, its PGxOne Plus test interrogates 50 genes with coverage of ~200 genetic variants and provides recommendation on over 300 drugs. The company also offers OncoGxOne and OncoGxSelect for tumor profiling to guide selection of targeted therapies, cancer supportive care, and inherited cardiovascular diseases via its partnership with Health in Code.

Under the terms of one agreement, Admera will be gain access to the existing physician network of Angsana Molecular & Diagnostics Laboratory Ltd. Headquartered in Singapore, Angsana has additional offices in Hong Kong and Malaysia. The company develops molecular diagnostic assays for allergy, fetal maternal health, oncology, and pharmacogenetics.

Other agreements include distribution partnerships for Admeras complete product portfolio with Biois Corp., headquartered in Seoul, South Korea, and AllBio Pharma Corp., providing access to large population centers in Taiwan. Biois is molecule diagnosis company with proprietary technologies to detect disease at an early stage from blood. AllBio is a life science and precision medicine service provider in Taiwan.

Vice President of Business Development Brady Millican stated, These partnerships align with our strategic goals of expanding our global footprint and making pharmacogenomics standard of care globally. We are especially excited about our new partners interests in deploying pharmacogenomics within cardiovascular and oncology clinics.

Additional terms of the three agreements were not disclosed.

About Admera Health

Admera Health is a CLIA-certified and CAP-accredited advanced molecular diagnostics company focused on personalized medicine, non-invasive cancer testing, digital health, and providing research use only services. Research and development efforts are dedicated to developing cutting-edge diagnostics that span the continuum of care. Utilizing next generation technology platforms and advanced bioinformatics, Admera Health seeks to redefine disease screening, diagnosis, treatment, monitoring, and management through its innovative, personalized solutions. It is our mission to deliver transformative, valuable solutions for patients, physicians, and clinical researchers. We are committed to improving the health and well-being of our global community through the direct delivery of personalized, medically actionable results.

Admera Health Contact:

Brady Millican,VP Business

(c) 2003-2017 SudanTribune - All rights reserved. Provided by SyndiGate Media Inc. (

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Last Chance
Sep 24: Using Effective Communication to Reduce Medication Errors
Sep 25: Management of Major Depressive Disorders
Sep 26: Vitamins, Minerals, and Electrolytes in Older Adults
Sep 27: Medication Use During Pregnancy & Lactation
Sep 28: An Integrative Approach to Managing Arthritis
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement